Tyra Biosciences, Inc.

NASDAQ:TYRA

10.17 (USD) • At close June 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 000000.502000000000000000
Cost of Revenue 0000.1260.1220.1020.0820.08600.0820.0820.0690.0640.050.0410.0270.0220000
Gross Profit 000-0.126-0.1220.4-0.082-0.0860-0.082-0.082-0.069-0.064-0.05-0.041-0.027-0.0220000
Gross Profit Ratio 000000.797000000000000000
Reseach & Development Expenses 24.96422.1822.69717.87117.08120.57519.27112.16210.40810.410.91512.0479.6457.255.4844.3813.5222.9281.8621.420.993
General & Administrative Expenses 6.8867.5645.9075.5355.1194.9574.6923.8523.9264.6182.733.3815.1892.6821.1541.1270.6890.7490.470.4120.463
Selling & Marketing Expenses 000000000000000000000
SG&A 6.8867.5645.9075.5355.1194.9574.6923.8523.9264.6182.733.3815.1892.6821.1541.1270.6890.7490.470.4120.463
Other Expenses 00000-0.011-0.005-0.0210-0.0330.005-0.013-0.01-0.003-0.007-0.0080-0.006-0.00700
Operating Expenses 31.8529.74428.60423.40622.225.53223.96316.01414.33415.01813.64515.42814.8349.9326.6385.5084.2113.6772.3321.8391.474
Operating Income -31.85-29.744-28.604-23.532-22.322-25.634-23.963-16.014-14.334-15.018-13.645-15.428-14.834-9.932-6.638-5.508-4.211-3.677-2.332-1.832-1.456
Operating Income Ratio 00000-51.064000000000000000
Total Other Income Expenses Net 3.7034.1734.5884.834.132.8042.8112.7422.4542.1231.1360.3330.0080.002-0.005-0.0040.002-0.008-0.007-0.006-0.018
Income Before Tax -28.147-25.571-24.016-18.702-18.192-22.83-21.152-13.272-11.88-12.895-12.509-15.095-14.826-9.93-6.643-5.512-4.209-3.685-2.339-1.838-1.474
Income Before Tax Ratio 00000-45.478000000000000000
Income Tax Expense 00000.0798.033-2.816-2.7630-32.387-1.136-0.333-0.008-0.055-0.002-0.0040-0.036000
Net Income -28.147-25.571-24.016-18.702-18.192-22.83-21.152-13.272-11.8819.492-11.373-14.762-14.818-9.93-6.643-5.512-4.209-3.685-2.339-1.838-1.474
Net Income Ratio 00000-45.478000000000000000
EPS -0.470-0.41-0.32-0.35-0.53-0.49-0.31-0.280.46-0.27-0.35-0.36-0.24-0.72-0.15-0.19-0.16-0.1-1.27-1.07
EPS Diluted -0.470-0.41-0.32-0.35-0.53-0.49-0.31-0.280.46-0.27-0.35-0.36-0.24-0.72-0.15-0.19-0.16-0.1-1.27-1.07
EBITDA -31.707-29.6-28.477-23.406-22.2-25.532-23.881-15.925-14.251-14.936-13.563-15.36-14.77-9.882-6.597-5.481-4.189-3.696-2.316-1.824-1.452
EBITDA Ratio 00000-50.861000000000000000